Indirect Treatment Comparisons and Biologics

Affiliations

¹ Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pa.
² Division of Pulmonary, Allergy Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa. Electronic address: andrea.apter@uphs.upenn.edu.

Editorial

David Mauger et al. J Allergy Clin Immunol Pract. 2019 Jan.

. 2019 Jan;7(1):131-133.

doi: 10.1016/j.jaip.2018.11.008.

¹ Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pa.
² Division of Pulmonary, Allergy Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa. Electronic address: andrea.apter@uphs.upenn.edu.

Erratum in

Correction.
[No authors listed] [No authors listed] J Allergy Clin Immunol Pract. 2019 Mar;7(3):1096. doi: 10.1016/j.jaip.2019.01.010. J Allergy Clin Immunol Pract. 2019. PMID: 30832888 No abstract available.

No abstract available

Anti-IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparison.
Busse W, Chupp G, Nagase H, Albers FC, Doyle S, Shen Q, Bratton DJ, Gunsoy NB. Busse W, et al. J Allergy Clin Immunol. 2019 Jan;143(1):190-200.e20. doi: 10.1016/j.jaci.2018.08.031. Epub 2018 Sep 8. J Allergy Clin Immunol. 2019. PMID: 30205189 Review.
Reslizumab Compared with Benralizumab in Patients with Eosinophilic Asthma: A Systematic Literature Review and Network Meta-Analysis.
Casale TB, Pacou M, Mesana L, Farge G, Sun SX, Castro M. Casale TB, et al. J Allergy Clin Immunol Pract. 2019 Jan;7(1):122-130.e1. doi: 10.1016/j.jaip.2018.08.036. Epub 2018 Sep 11. J Allergy Clin Immunol Pract. 2019. PMID: 30217529